Alignment Healthcare, Inc. (ALHC) vs Sarepta Therapeutics, Inc. (SRPT)

A side-by-side comparison of Alignment Healthcare, Inc. and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALHC vs SRPT

growth of $100 · dividends reinvested · last 6y
ALHC -50.9% (-11.2%/yr)SRPT -76.6% (-21.5%/yr)ALHC compounded faster over this window
50100150200Start $10020222023202420252026$49$23
ALHC SRPT

ALHC vs SRPT: by the numbers

  • •SRPT is the larger company ($1.83B vs $1.74B market cap).
  • •ALHC is profitable (0.89% net margin) while SRPT runs a net loss (-6.93%).
  • •ALHC grew revenue faster over the past five years (33.83% vs 26.90% CAGR).

Metrics side by side

Valuation

MetricALHCSRPT
P/E ratio44.86N/A
Forward P/E46.105.38
P/S ratio0.380.93
P/B ratio6.551.20
EV / EBITDA15.87N/A

Profitability

MetricALHCSRPT
Gross margin12.55%58.56%
Operating margin1.20%-29.92%
Net margin0.89%-6.93%
ROE15.35%-8.95%
ROIC9.23%-5.33%

Growth (annualized)

MetricALHCSRPT
Revenue CAGR (5Y)33.83%26.90%
Total return CAGR (5Y)-12.15%-28.74%

Frequently asked

Which has grown faster, ALHC or SRPT?
Over the past five years, ALHC grew revenue faster — ALHC at a 33.83% CAGR versus SRPT at 26.90%.
Is ALHC or SRPT more profitable?
ALHC runs the higher net margin — ALHC at 0.89% versus SRPT at -6.93%.
How have ALHC and SRPT total returns compared?
Over the past 5 years, ALHC delivered -12.15% and SRPT delivered -28.74% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.